The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
Abstract
OBJECTIVE: Two antidepressant medication combinations were compared with selective serotonin reuptake inhibitor monotherapy to determine whether either combination produced a higher remission rate in first-step acute-phase (12 weeks) and long-term (7 months) treatment. METHOD: The single-blind, prospective, randomized trial enrolled 665 outpatients at six primary and nine psychiatric care sites. Participants had at least moderately severe nonpsychotic chronic and/or recurrent major depressive disorder. Escitalopram (up to 20 mg/day) plus placebo, sustained-release bupropion (up to 400 mg/day) plus escitalopram (up to 20 mg/day), or extended-release venlafaxine (up to 300 mg/day) plus mirtazapine (up to 45 mg/day) was delivered (1:1:1 ratio) by using measurement-based care. The primary outcome was remission, defined as ratings of less than 8 and less than 6 on the last two consecutive applications of the 16-item Quick Inventory of Depressive Symptomatology--Self-Report. Secondary outcomes included side effect burden, adverse events, quality of life, functioning, and attrition. RESULTS: Remission and response rates and most secondary outcomes were not different among treatment groups at 12 weeks. The remission rates were 38.8% for escitalopram-placebo, 38.9% for bupropion-escitalopram, and 37.7% for venlafaxine-mirtazapine, and the response rates were 51.6%-52.4%. The mean number of worsening adverse events was higher for venlafaxine-mirtazapine (5.7) than for escitalopram-placebo (4.7). At 7 months, remission rates (41.8%-46.6%), response rates (57.4%-59.4%), and most secondary outcomes were not significantly different. CONCLUSIONS: Neither medication combination outperformed monotherapy. The combination of extended-release venlafaxine plus mirtazapine may have a greater risk of adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Self-citationThe Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Self-citationTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Self-citationThe Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Self-citationSangha, O., Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (2003) · Arthritis Care & Research · doi:10.1002/art.10993 · Cited by 1,806
(1990) · Springer eBooks · doi:10.1007/978-3-642-74034-3 · Cited by 1,523
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331
Self-citationBupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Self-citationMedication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002
Self-citationFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Self-citationThe Altman Self-Rating Mania Scale
Altman, E. G., Hedeker, D., Peterson, J. L., & Davis, J. M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00548-3 · Cited by 831
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707
Self-citationRush, A. J., Bernstein, I. H., Trivedi, M. H., Carmody, T. J., Wisniewski, S., Mundt, J. C., Shores-Wilson, K., Biggs, M. M., Woo, A., Nierenberg, A. A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.022 · Cited by 385
Self-citationMcGrath, P. J., Stewart, J. W., Fava, M., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Thase, M. E., Davis, L., Biggs, M. M., Shores-Wilson, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1531 · Cited by 350
Self-citationBlier, P., Ward, H. E., Tremblay, P., Laberge, L., Hébert, C., & Bergeron, R. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020186 · Cited by 316
Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects
WISNIEWSKI, S. R., RUSH, A. J., BALASUBRAMANI, G. K., TRIVEDI, M. H., & NIERENBERG, A. A. (2006) · Journal of Psychiatric Practice · doi:10.1097/00131746-200603000-00002 · Cited by 288
Self-citationPredictive and treatment validity of life satisfaction and the Quality of Life Inventory
Frisch, M. B., Clark, M. P., Rouse, S. V., Rudd, M. D., Paweleck, J. K., Greenstone, A., & Kopplin, D. A. (2005) · Assessment · doi:10.1177/1073191104268006 · Cited by 287
Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
Rush, A. J., Zimmerman, M., Wisniewski, S. R., Fava, M., Hollon, S. D., Warden, D., Biggs, M. M., Shores-Wilson, K., Shelton, R. C., Luther, J. F., et al. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.005 · Cited by 254
Self-citationResults of the DSM-IV mood disorders field trial
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.843 · Cited by 249
A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine
Carpenter, L. L., Yasmin, S., & Price, L. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01262-8 · Cited by 244
Neurobiological basis of depression: an update
Kalia, M. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.009 · Cited by 201
Nelson, J. C., Mazure, C. M., Jatlow, P. I., Bowers, M. B., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.007 · Cited by 189
Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison
Poirier, M.-F., & Boyer, P. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.12 · Cited by 185
Perry, P. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00014-6 · Cited by 180
Venlafaxine and paroxetine in treatment-resistant depression
Gregson, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.6.591a · Cited by 171
Keller, M. B., Gelenberg, A. J., Hirschfeld, R. M. A., Rush, A. J., Thase, M. E., Kocsis, J. H., Markowitz, J. C., Fawcett, J. A., Koran, L. M., Klein, D. N., et al. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1107 · Cited by 161
Self-citationBlier, P., Gobbi, G., Turcotte, J. E., de Montigny, C., Boucher, N., Hébert, C., & Debonnel, G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.015 · Cited by 161
Fava, M., & Rush, A. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091771 · Cited by 160
Self-citationTrivedi, M. H., Rush, A., Gaynes, B., Stewart, J. W., Wisniewski, S., Warden, D., Ritz, L., Luther, J., Stegman, D., DeVeaugh-Geiss, J., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301390 · Cited by 157
Self-citationFava, M., Iosifescu, D. V., Pedrelli, P., & Baer, L. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000201934 · Cited by 143
Self-citationAugmentation and combination strategies in treatment-resistant depression.
D, M. F. M. (2001) · PubMed · Cited by 139
Maes, M. H. J., Libbrecht, I., Hunsel, F. V., Campens, D., & Meltzer, H. Y. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00014 · Cited by 133
Mourad, J., Waeber, B., Zannad, F. E., Laville, M., Duru, G., & jak, M. A. (2004) · Journal of Hypertension · doi:10.1097/00004872-200412000-00021 · Cited by 132
When Should a Trial of Fluoxetine for Major Depression Be Declared Failed?
Quitkin, F. M., Petkova, E., McGrath, P. J., Taylor, B. P., Beasley, C. M., Stewart, J. W., Amsterdam, J. D., D, M. F. M., Rosenbaum, J. F., Reimherr, F. W., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.734 · Cited by 100
Self-citationMischoulon, D., Nierenberg, A. A., Kizilbash, L., Rosenbaum, J. F., & D, M. F. M. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500509 · Cited by 81
Self-citationChronicity of depressive episode in relation to antidepressant-placebo response.
Khan, A., Dager, S. R., Cohen, S., Avery, D., Scherzo, B., & Dünner, D. L. (1991) · PubMed · Cited by 62
Leuchter, A. F., Lesser, I. M., Trivedi, M. H., Rush, A. J., Morris, D. W., Warden, D., D, M. F. M., Wisniewski, S. R., Luther, J. F., Perales, M. L., et al. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000336754.19566.65 · Cited by 46
Self-citationWisniewski, S., Eng, H. F., Meloro, L., Gatt, R., Ritz, L., Stegman, D., Trivedi, M., Biggs, M., Friedman, E., Shores-Wilson, K., et al. (2004) · Clinical Trials · doi:10.1191/1740774504cn035oa · Cited by 42
Self-citationGeneral versus Specific Inquiry with SAFTEE
Levine, J., & Schooler, N. R. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199212000-00017 · Cited by 28
Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression?
Stewart, J. W., McGrath, P. J., Deliyannides, R. A., & Quitkin, F. M. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000361276.88339.44 · Cited by 17
Self-citation
Cited by
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Controversy remains regarding this practice but many psychiatrists use antidepressant combinations in some of their depressed patients with positive reports (Dodd et al., 2005; Keks et al., 2007; Malhi et al., 2013a; Ng et al., 2006; Rush et al., 2011; Thase, 2013).”
BackgroundMurrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Cross-trial prediction of treatment outcome in depression: a machine learning approach
Chekroud, A. M., Zotti, R. J., Shehzad, Z., Gueorguieva, R., Johnson, M. K., Trivedi, M. H., Cannon, T. D., Krystal, J. H., & Corlett, P. R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00471-x · Cited by 676
Self-citation
Metadata
- Authors
- Rush, A. J., Trivedi, M. H., Stewart, J. W., Nierenberg, A. A., Fava, M., Kurian, B. T., Warden, D., Morris, D. W., Luther, J. F., Husain, M. M., Cook, I. A., Shelton, R. C., Lesser, I. M., Kornstein, S. G., & Wisniewski, S. R.
- Venue
- American Journal of Psychiatry
- Published
- 2011-07
- Volume
- 168
- Issue
- 7
- Pages
- 689-701
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2178666919
- Cited by
- 372
- References
- 46
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.